The last financial report show the Infusion business was break-even so selling part of the "farm" for $6.5M isn't a negative, they need to re-direct their focus on ADAPT and in particular TAVR (currently it's MC is lower than most ASX listed start-up biotech stock......)
Ann: Notice to terminate distribution agreement, page-13
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.26 |
Change
-0.140(0.91%) |
Mkt cap ! $321.3M | |||
| Open | High | Low | Value | Volume |
| $15.15 | $15.26 | $15.01 | $53.34K | 3.522K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.39 | 387 | 1 |
View Market Depth
| Last trade - 12.38pm 22/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |